Fundraising Fox

Forepont Capital Partners

Venture capital

New York · Pre-Seed–Late Stage · 26 people tracked

Also known as FOREPONT CAPITAL LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Forepont Capital Partners invests in early-stage companies before their inflection point, targeting ventures with the potential to improve the lives of millions. Its focus centers on 'Brain AI' — artificial intelligence that advances neuroscience — and applications of that technology across healthcare, safety, education, defense, and device control. The firm also backs biological frameworks that improve AI performance and efficiency and unlock new capabilities. Forepont typically retains a board seat in most portfolio companies, sizing its positions to maintain influence, and supports its companies scientifically, technologically, and strategically through its expertise and network.

Source: firm website, verified Aug 25, 2026.

Stage
Pre-Seed–Late Stage
HQ
New York, New York, US
Leads rounds
Leads
Instruments
Equity
Founded
2017
Private fund assets
$89.1M
VC funds
2
Tracked investments
16

Team · 26 people

from the firm's website & curated & public directories
David Putrino· Venture Partner
Doug Weber· Venture Partner
A. Cheikh Lahlou· Senior Advisor
David Norton· Board member
Doug Siekierski
Dr. Ismail Kola· Senior Advisor
Dr. Philippe Schaison· Board member
Geoff Kalish· Board member
K. Alataris

Holds a PhD.

Karine Montlucin
Laurent Bouyoux· Board member
Michel Vounatsos· Senior Advisor
Per Wold-Olsen· Board member
Philippe Schaison· Board member

What they invest in

from 14 of 16 portfolio companies

Medical Devices ×10Biotech ×7Deep Tech ×6Healthtech ×6Digital Health ×5AI & Machine Learning ×2Data & Infrastructure ×1Enterprise Software ×1

HQs:France×5United States×5

Who they back

founder profiles across 8 portfolio companies
25%
solo founders
2 of 8 mapped founding teams

Founding team size:solo founder×22 founders×53 founders×1

Investments · 16 tracked

founders shown can be your intro path

By year:2024 · 12021 · 12018 · 13 dated

Resteraresterasleep.com✓ verified

Restera develops neurostimulation and sleep therapy medical devices, bringing over 75 years of combined expertise in these areas with 100+ FDA approvals.

Deep TechHardwareHealthtechMedical Devices

Rick O'Connor(CEO)

Co-investorsSupermoon CapitalAphelion CapitalDns CapitalGreatPoint Ventures

AlterDiagalterdiag.comin𝕏

AlterDiag is a diagnostics company founded by executives with backgrounds in immunology R&D and business strategy.

BiotechDigital HealthHealthtechMedical DevicesParis, FR

Karine(Founder)Cédric(Founder)

Ansell A/Sansellatx.comin

Ansella Therapeutics develops novel vaginal formulations for women's health conditions using biomimetic materials science and biomedical engineering, focused on treating menopause, vaginal dryness, dyspareunia, vaginal mucositis, endometriosis, uterine fibroids, and vaginal infections.

BiotechFemTechMedical DevicesAustin, US

Basecamp Vascularbasecampvascular.comin𝕏

BCV Systems develops a mechatronic guidewire system using shape memory alloy actuators to optimize navigation during minimally invasive endovascular procedures for stroke treatment and other vascular interventions.

Deep TechHealthtechMedical DevicesParis, FR

Dr Raphaël Blanc(President)Jérôme Szewczyk(Researcher at the Institute of Intelligent Systems and Robotics ISIR, Professor at Sorbonne University)Jean-Baptiste Cazeneuve(CTO, Mechatronic Engineer)

Bay Bridge Digitalbaybridgedigital.comJun 2018

BayBridgeDigital is a Salesforce consulting firm that helps retailers, healthcare, real estate, education, and hospitality companies with digital transformation through CRM implementation, data management, and cloud platform integration.

Data & InfrastructureEnterprise SoftwareSaaSNew York, US

Alain Attias(Founder)inGuy Jerusalmi(Executive Officer)ALAIN ATTIAS(Executive Officer)

Becare Linkbecarelink.comin

BeCareLink builds AI-enhanced mobile platforms for remote neurological assessments, allowing patients to monitor their neurological health from home while helping clinicians and researchers track disease progression.

AI & Machine LearningDigital HealthHealthtech

Lawrence Rubin(Co-founder)Charisse D. Litchman(Co-founder)

Biospeediabiospeedia.comin𝕏

BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2.

BiotechHealthtechMedical Devices

Evelyne Begaud(Co-founder & President)Yves Germani(Co-founder & Chief Scientific Officer)

Blackrock Neurotechblackrockneurotech.comin𝕏

Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.

BiotechDeep TechMedical Devices

Florian Solzbacher(Co-Founder & CSO)Marcus Gerhardt(Co-Founder & CEO)inThomas Thiele(CFO)

BoardChristian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)

Co-investors2050 CapitalCatalio Capital Management, LP

Exeliom Biosciencesexeliombio.comin

Exeliom Biosciences is a biotechnology company developing biotherapies, with work in areas such as inflammatory bowel disease (Crohn's and colitis).

BiotechDeep TechDigital HealthMedical DevicesParis, FR

Harry Sokol(Scientific Co-founder)

Co-investorsBpifranceAgoranov

GPN VaccinesJun 2024 · $18M

BiotechWilmington, US

Timothy Hirst(Executive Officer, Director)James Selkirk(Executive Officer)

Co-investorsKern Capital, LLCShearwater Capital

GPN Vaccinesgpnvaccines.com

Co-investorsShearwater Capital

Invicta Medicalinvictamedical.com

Co-investorsAphelion Capital

Okeirookeiro.comin

Okeiro is a medical platform using predictive algorithms to monitor transplant and chronic disease patients.

AI & Machine LearningDigital HealthMedical Devices

Precisionprecisionneuro.ioin𝕏

Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.

Deep TechDigital HealthMedical Devices

Co-investorsB Capital GroupB4 CapitalDraper AssociatesSteadview Capital

Precision Neurosciencein

HealthtechNew York, US

Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)

BoardEric M. Attias(Director)Howard Morgan(Director)in

Co-investorsAlumni VenturesB Capital GroupBasecamp FundSCI VenturesSteadview Capital

Synchronsynchron.comin𝕏May 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)inThomas Oxley(Founder)in

BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)

Co-investorsARCH Venture PartnersID8 InvestmentsKaleida CapitalKhosla VenturesBezos ExpeditionsIn-Q-Tel+4 more

Portfolio news

latest coverage across their companies
Precision Agriculture Companies

Precision · igrownews.com · Aug 22, 2026

Sell or Invest in Restera Stock Pre-IPO

Restera · nasdaqprivatemarket.com · Apr 3, 2026

Trysignalbase

Precision Neuroscience · trysignalbase.com · Mar 9, 2026

Frequently asked questions

How many investments has Forepont Capital Partners made?
Forepont Capital Partners has 13 tracked investments.
What stage does Forepont Capital Partners invest at?
Forepont Capital Partners invests at the Pre-Seed, Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does Forepont Capital Partners focus on?
Forepont Capital Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Defense Tech, EdTech, Healthtech, Medical Devices.
Where is Forepont Capital Partners located?
Forepont Capital Partners is headquartered in New York, US.
Does Forepont Capital Partners lead rounds?
Yes, Forepont Capital Partners leads investment rounds.
Who does Forepont Capital Partners co-invest with?
Forepont Capital Partners most often shares deals with ARCH Venture Partners, B Capital Group, Draper Associates, among 13 tracked co-investors.

Images

Forepont Capital Partners photoForepont Capital Partners photoForepont Capital Partners photoForepont Capital Partners photoForepont Capital Partners photoForepont Capital Partners photo

Similar investors

Featured in lists